| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/30/2009 | US20090191136 Use of active substance complexes of panthenol, glycerol, citrate and/or bisabolol against pollen allergies |
| 07/30/2009 | US20090191135 Methods for the dispersion of water-soluable or hydrophilic substances in a supercritically pressurized fluid |
| 07/30/2009 | US20090191134 Stable aerosol pharmaceutical formulations |
| 07/30/2009 | US20090191133 Modulation of stat 6 expression for the treatment of airway hyperresponsiveness |
| 07/30/2009 | US20090191131 Use of particulate contrast agents in diagnostic imaging for studying physiological paramaters |
| 07/30/2009 | US20090191128 Core-shell nanoparticles for thearapy and imaging purposes |
| 07/30/2009 | US20090188497 Medical product containing tiotropium |
| 07/30/2009 | US20090188496 Inhalable tiotropium and container therefor |
| 07/30/2009 | US20090188495 Pre-metered dry powder inhaler for moisture-sensitive medicaments |
| 07/30/2009 | US20090188491 Medicaments |
| 07/30/2009 | CA2713373A1 Abuse resistant melt extruded formulation having reduced alcohol interaction |
| 07/30/2009 | CA2713197A1 Combinations of oral medicaments bonded by a wrapping |
| 07/30/2009 | CA2713128A1 Pharmaceutical dosage form |
| 07/30/2009 | CA2713105A1 Methods of treating viral infections |
| 07/30/2009 | CA2711537A1 Method for lyophilising particles having a pharmaceutical compound contained therein and a pharmaceutical pack containing such particles |
| 07/29/2009 | EP2082755A1 Monolithic alginate implants networked in situ |
| 07/29/2009 | EP2082754A1 Bone defect filler, release-controlled carrier, and their production methods |
| 07/29/2009 | EP2082753A2 Drug release stent coating process |
| 07/29/2009 | EP2082750A1 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 07/29/2009 | EP2082748A1 Agent preparations and medicine capable of generating and containing thrombin |
| 07/29/2009 | EP2082742A1 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic |
| 07/29/2009 | EP2082737A2 Methods of inducing terminal differentiation |
| 07/29/2009 | EP2082735A1 Amorphous Aripiprazole and Process for the Preparation thereof |
| 07/29/2009 | EP2082734A2 Temperature-sensitive nano-carriers |
| 07/29/2009 | EP2082733A1 Use of lipid components against pollen allergies |
| 07/29/2009 | EP2082732A1 Orodispersible tablets of prednisolone |
| 07/29/2009 | EP2082731A1 Use of a combination of hesperidin and a micro-organism to act on the barrier function of the skin |
| 07/29/2009 | EP2081960A1 Intranasal delivery of polypeptides and proteins |
| 07/29/2009 | EP2081669A2 Granules, tablets and granulation |
| 07/29/2009 | EP2081574A1 Buprenorphine-containing non-pressurised spray composition for transmucosal administration |
| 07/29/2009 | EP2081563A1 Pharmaceutical formulations |
| 07/29/2009 | EP2081562A2 Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief |
| 07/29/2009 | EP2081559A2 Procedure and devices for the controlled obtaining of dry saline aerosols with therapeutic effect |
| 07/29/2009 | EP2081557A1 Colonic delivery using zn/pectin beads with a eudragit coating. |
| 07/29/2009 | EP2081556A1 Stable imatinib compositions |
| 07/29/2009 | EP2081555A2 Pharmaceutical compositions for the oral or rectal administration of protein substances |
| 07/29/2009 | EP2081554A2 Atorvastatin pharmaceutical compositions |
| 07/29/2009 | EP2081553A2 Stable antibody formulations |
| 07/29/2009 | EP2081552A2 Spontaneously forming ellipsoidal phospholipid unilamellar vesicles |
| 07/29/2009 | EP2081551A1 Dried reconstituted vesicle formation for pharmaceutical application |
| 07/29/2009 | EP2081550A2 Coating capsules with active pharmaceutical ingredients |
| 07/29/2009 | EP2081549A2 Ophthalmic compositions containing diglycine |
| 07/29/2009 | EP2081547A2 Galenic form for the trans-mucosal delivery of active ingredients |
| 07/29/2009 | EP2081546A2 Multiple unit tablet compositions of benzimidazole compounds |
| 07/29/2009 | EP2081545A2 Methods of producing microparticles |
| 07/29/2009 | EP2005990A9 Microneedle device and transdermal administration device provided with microneedles |
| 07/29/2009 | EP1993515B1 Method for solubilizing, dispersing, and stabilizing materials, products manufactured according to said method, and use thereof |
| 07/29/2009 | EP1987817B1 Pharmaceutical composition of microspheres for preventing diabetic foot amputation |
| 07/29/2009 | EP1885721B1 Metal chelates of polyaminocarboxylic macrocyclic derivatives and use thereof in diagnostic imaging |
| 07/29/2009 | EP1883390B1 Topical compositions |
| 07/29/2009 | EP1871340B1 Anti-irritating cough mixture containing extracts from island moss and mallow as well as zinc derivatives |
| 07/29/2009 | EP1793764A4 Growth factor encapsulation system for enhancing bone formation |
| 07/29/2009 | EP1734929A4 Microparticles for cell delivery |
| 07/29/2009 | EP1711170B1 Transdermal delivery device for dihydropyridine type calcium antagonists containing two fatty acids |
| 07/29/2009 | EP1694370A4 Wound care products containing keratin |
| 07/29/2009 | EP1631264B1 Immunogenic compositions based on biodegradable microparticles comprising a diphtheria- and a tetanus toxoid |
| 07/29/2009 | EP1624896B1 Method for the production of a stable injectable formulation made of paclitaxel |
| 07/29/2009 | EP1572897B1 Ordered biological nanostructures formed from chaperonin polypeptides |
| 07/29/2009 | EP1495014B1 Flavanoids derivatives as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| 07/29/2009 | EP1435910B1 Novel cyclosporin analog microemulsion preconcentrates |
| 07/29/2009 | EP1411895B2 Oral pharmaceutical composition comprising an active principle capable of being subjected to high effect during its first passage through the intestine |
| 07/29/2009 | EP1278494B1 Device and method for treating urinary incontinence in females |
| 07/29/2009 | EP1260215B1 Rapidly disintegrable tablet containing polyvinyl alcohol |
| 07/29/2009 | EP0879048B2 Method for making tablets using trehalose |
| 07/29/2009 | CN101495105A Delivery device having self-assembling dendritic polymers and method of use thereof |
| 07/29/2009 | CN101495104A Coating composition comprising starch |
| 07/29/2009 | CN101495103A Pharmaceutical preparation for oral administration with controlled drug release in the small intestine colon and process of prepartion thereof |
| 07/29/2009 | CN101495102A Bulking of soft tissue |
| 07/29/2009 | CN101495101A Sugar-coated preparation and process for producing the same |
| 07/29/2009 | CN101495100A Sustained release pharmaceutical formulation comprising phenylephrine |
| 07/29/2009 | CN101495099A Sustained release pharmaceutical dosage containing phenylephrine |
| 07/29/2009 | CN101495098A Oral pharmaceutical composition of a poorly water-soluble active substance |
| 07/29/2009 | CN101495097A Spherical crude granule and method for production thereof |
| 07/29/2009 | CN101495096A Nanoparticulate posaconazole formulations |
| 07/29/2009 | CN101495095A Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation andpharmaceutical formulations containing same |
| 07/29/2009 | CN101495094A Osmotic delivery systems and piston assemblies |
| 07/29/2009 | CN101495093A A drug delivery system with thermoswitchable membranes |
| 07/29/2009 | CN101495092A Cosmetic compositions with encapsulated pigments and a method for using |
| 07/29/2009 | CN101491520A Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 07/29/2009 | CN101491509A Cyclovirobuxine-D sustained-release micro-pill capsules and preparation method thereof |
| 07/29/2009 | CN101491508A Preparation method of aspirin Intestine-soluble micro-pill capsules |
| 07/29/2009 | CN101491507A Colloidal bismuth tartrate medicine and preparation method and use thereof |
| 07/29/2009 | CN101491506A Acarbose chewing tablets |
| 07/29/2009 | CN101491505A Ropinirole hydrochloride sustained-release preparation and preparation method thereof |
| 07/29/2009 | CN101491504A Lansoprazole production technique |
| 07/29/2009 | CN101491503A Polyinosinic dropping-pills for pet and preparation method thereof |
| 07/29/2009 | CN101491502A Cefuroxime sodium freeze dry power and preparation method thereof |
| 07/29/2009 | CN101491501A Preparation method of ambroxol for injection |
| 07/29/2009 | CN101491500A Meglumine adenosine cyclphosphate microspheres and production method thereof |
| 07/29/2009 | CN101491499A Composite liposome for injection containing 12 vitamins and preparation method thereof |
| 07/29/2009 | CN101491498A aFGF liposome, preparation method and use thereof |
| 07/29/2009 | CN101491497A Toltrazuril suspension preparation capable of being effectively uniformly dispersed in water and preparation method thereof |
| 07/29/2009 | CN101491496A Sitafloxacine injection and preparation method thereof |
| 07/29/2009 | CN101491495A Salvianolic acid B magnesium injection, preparation method and use thereof |
| 07/29/2009 | CN101491494A Praziquantel slow-released Implants for animals and preparation method thereof |
| 07/29/2009 | CN101491493A Ferulic acid piperazine slow-release medicine preparation |
| 07/29/2009 | CN100519735C Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 07/29/2009 | CN100519643C Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from |
| 07/29/2009 | CN100519558C Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and the use thereof in the production of a medicament |
| 07/29/2009 | CN100518831C Solid nano-medicine and preparing method thereof |